首页> 外文期刊>Medicine. >Continuous venovenous hemofiltration in the management of paraquat poisoning: A meta-analysis of randomized controlled trials
【24h】

Continuous venovenous hemofiltration in the management of paraquat poisoning: A meta-analysis of randomized controlled trials

机译:百草枯中毒管理中的连续铰接血液过滤:随机对照试验的荟萃分析

获取原文
获取外文期刊封面目录资料

摘要

Background: Paraquat (PQ) poisoning is a widespread occurrence, especially in underdeveloped areas. The treatment of PQ poisoning has always been difficult, and there is currently no definite effective treatment. Continuous venovenous hemofiltration (CVVH) treatment for PQ poisoning has been widely used in clinical practice; however, its effect remains uncertain. Accordingly, the purpose of this meta-analysis was to evaluate the efficacy of CVVH in the treatment of PQ poisoning. Methods: We searched for relevant trials using PubMed, Embase, the Cochrane Library, and 3 Chinese databases, the Chinese BioMedical Literature Database, National Knowledge Infrastructure Database, and Wanfang Database. We included all qualified randomized controlled trials (RCTs) of CVVH treatment for patients with PQ poisoning. The primary outcome was mortality, while the secondary outcomes included the survival time and constituent ratios of death due to respiratory failure and circulatory failure. Results: Three RCTs involving 290 patients were included. The mortality rates of the intervention and control groups were 57.9% and 61.0%, respectively. Pooled analysis demonstrated no significant difference in mortality between the CVVH treatment and control groups (risk ratio [RR] 0.94, 95% confidence interval [CI]: 0.78–1.15, P = .56), with a low level of heterogeneity (X2 = 1.75, I 2 = 0%). However, the CVVH group was associated with a longer survival time compared to the control group (weighted mean difference 1.73, 95% CI: 0.56–2.90, P = .004). Respiratory failure as the cause of death was more common in the CVVH group, as compared with the control group (RR 1.66, 95% CI: 1.24–2.23, P = .0008), whereas patients in the control group were more likely to die from circulatory failure than in the CVVH group (RR 0.56, 95% CI: 0.40–0.81, P = .002). Conclusion: Although CVVH treatment might not noticeably reduce mortality for patients with PQ poisoning, it can prolong the survival time of the patients and improve the stability of the circulatory system, thereby enabling further treatment.
机译:背景:百草枯(PQ)中毒是一种广泛的发生,特别是在欠发达地区。 PQ中毒的治疗始终困难,目前没有明确的有效治疗。 PQ中毒的连续铰接血液过滤(CVVH)治疗已广泛用于临床实践;然而,其效果仍然不确定。因此,该荟萃分析的目的是评估CVVH治疗PQ中毒的疗效。方法:我们搜索了使用PubMed,Embase,Cochrane图书馆和3个中文数据库,中国生物医学文献数据库,国家知识基础设施数据库和Wanfang数据库的相关试验。我们包括PQ中毒患者的CVVH治疗的所有合格的随机对照试验(RCT)。主要结果是死亡率,而次要结果包括由于呼吸衰竭和循环衰竭导致的生存时间和成分比死亡率。结果:包括涉及290名患者的三个RCT。干预和对照组的死亡率分别为57.9%和61.0%。汇总分析表明,CVVH处理和对照组之间的死亡率没有显着差异(风险比[RR] 0.94,95%置信区间[CI]:0.78-1.15,P = .56),具有低水平的异质性(X sup xmlns:mrws =“http://webservices.ovid.com/mrws/1.0”> 2 = 1.75,i 2 = 0%)。然而,与对照组相比,CVVH组与更长的存活时间相关(加权平均差1.73,95%CI:0.56-2.90,P = .004)。与对照组相比,CVVH组中死亡原因的呼吸衰竭更常见(RR 1.66,95%CI:1.24-2.23,P = .0008),而对照组的患者更有可能死亡从循环衰竭比在CVVH组中(RR 0.56,95%CI:0.40-0.81,P = .002)。结论:虽然CVVH治疗可能不会显着降低PQ中毒患者的死亡率,但它可以延长患者的生存时间,提高循环系统的稳定性,从而能够进一步治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号